Phase I/IIa study of intratumoral/intracerebral or intravenous/intracerebral administration of Parvovirus H-1 (ParvOryx) in patients with progressive primary or recurrent glioblastoma multiforme: ParvOryx01 protocol
The treatment of patients with malignant brain tumors remains a major oncological problem. The median survival of patients with glioblastoma multiforme (GBM), the most malignant type, is only 15 months after initial diagnosis and even less after tumor recurrence. Improvements of standard treatment i...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
21 March 2012
|
| In: |
BMC cancer
Year: 2012, Jahrgang: 12 |
| ISSN: | 1471-2407 |
| DOI: | 10.1186/1471-2407-12-99 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1186/1471-2407-12-99 Verlag, kostenfrei, Volltext: https://doi.org/10.1186/1471-2407-12-99 
|
| Verfasserangaben: | Karsten Geletneky, Johannes Huesing, Jean Rommelaere, Joerg R. Schlehofer, Barbara Leuchs, Michael Dahm, Ottheinz Krebs, Magnus von Knebel Doeberitz, Bernard Huber and Jacek Hajda |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1572512350 | ||
| 003 | DE-627 | ||
| 005 | 20230426124308.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180502s2012 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1186/1471-2407-12-99 |2 doi | |
| 035 | |a (DE-627)1572512350 | ||
| 035 | |a (DE-576)502512350 | ||
| 035 | |a (DE-599)BSZ502512350 | ||
| 035 | |a (OCoLC)1341007961 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Geletneky, Karsten |d 1964- |e VerfasserIn |0 (DE-588)123632862 |0 (DE-627)706375475 |0 (DE-576)293799326 |4 aut | |
| 245 | 1 | 0 | |a Phase I/IIa study of intratumoral/intracerebral or intravenous/intracerebral administration of Parvovirus H-1 (ParvOryx) in patients with progressive primary or recurrent glioblastoma multiforme |b ParvOryx01 protocol |c Karsten Geletneky, Johannes Huesing, Jean Rommelaere, Joerg R. Schlehofer, Barbara Leuchs, Michael Dahm, Ottheinz Krebs, Magnus von Knebel Doeberitz, Bernard Huber and Jacek Hajda |
| 264 | 1 | |c 21 March 2012 | |
| 300 | |a 9 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 02.05.2018 | ||
| 520 | |a The treatment of patients with malignant brain tumors remains a major oncological problem. The median survival of patients with glioblastoma multiforme (GBM), the most malignant type, is only 15 months after initial diagnosis and even less after tumor recurrence. Improvements of standard treatment including surgery and radio-chemotherapy have not lead to major improvements. Therefore, alternative therapeutics such as oncolytic viruses that specifically target and destroy cancer cells are under investigation. Preclinical data of oncolytic parvovirus H-1 (H-1PV) infection of glioma cells demonstrated strong cytotoxic and oncosuppressing effects, leading to a phase I/IIa trial of H-1PV in patients with recurrent GBM (ParvOryx01). ParvOryx01 is the first trial with a replication competent oncolytic virus in Germany. | ||
| 650 | 4 | |a Glioblastoma Multiforme | |
| 650 | 4 | |a Maximum Tolerate Dose | |
| 650 | 4 | |a Newcastle Disease Virus | |
| 650 | 4 | |a Oncolytic Virus | |
| 650 | 4 | |a Recurrent Malignant Glioma | |
| 700 | 1 | |a Hüsing, Johannes |d 1965- |e VerfasserIn |0 (DE-588)124519687 |0 (DE-627)36339270X |0 (DE-576)294211306 |4 aut | |
| 700 | 1 | |a Knebel Doeberitz, Magnus von |e VerfasserIn |0 (DE-588)1022165291 |0 (DE-627)71693289X |0 (DE-576)364934239 |4 aut | |
| 700 | 1 | |a Hajda, Jacek |d 1970- |e VerfasserIn |0 (DE-588)12349656X |0 (DE-627)082589542 |0 (DE-576)293733341 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t BMC cancer |d London : BioMed Central, 2001 |g 12(2012) Artikel-Nummer 99, 9 Seiten |h Online-Ressource |w (DE-627)326643710 |w (DE-600)2041352-X |w (DE-576)107014645 |x 1471-2407 |7 nnas |a Phase I/IIa study of intratumoral/intracerebral or intravenous/intracerebral administration of Parvovirus H-1 (ParvOryx) in patients with progressive primary or recurrent glioblastoma multiforme ParvOryx01 protocol |
| 773 | 1 | 8 | |g volume:12 |g year:2012 |g extent:9 |a Phase I/IIa study of intratumoral/intracerebral or intravenous/intracerebral administration of Parvovirus H-1 (ParvOryx) in patients with progressive primary or recurrent glioblastoma multiforme ParvOryx01 protocol |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1186/1471-2407-12-99 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://doi.org/10.1186/1471-2407-12-99 |x Verlag |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20180502 | ||
| 993 | |a Article | ||
| 994 | |a 2012 | ||
| 998 | |g 12349656X |a Hajda, Jacek |m 12349656X:Hajda, Jacek |d 910000 |d 913000 |e 910000PH12349656X |e 913000PH12349656X |k 0/910000/ |k 1/910000/913000/ |p 10 |y j | ||
| 998 | |g 1022165291 |a Knebel Doeberitz, Magnus von |m 1022165291:Knebel Doeberitz, Magnus von |d 910000 |d 912000 |e 910000PK1022165291 |e 912000PK1022165291 |k 0/910000/ |k 1/910000/912000/ |p 8 | ||
| 998 | |g 124519687 |a Hüsing, Johannes |m 124519687:Hüsing, Johannes |d 910000 |d 913000 |e 910000PH124519687 |e 913000PH124519687 |k 0/910000/ |k 1/910000/913000/ |p 2 | ||
| 998 | |g 123632862 |a Geletneky, Karsten |m 123632862:Geletneky, Karsten |d 910000 |d 911200 |e 910000PG123632862 |e 911200PG123632862 |k 0/910000/ |k 1/910000/911200/ |p 1 |x j | ||
| 999 | |a KXP-PPN1572512350 |e 3007736129 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"language":["eng"],"recId":"1572512350","type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Gesehen am 02.05.2018"],"person":[{"family":"Geletneky","given":"Karsten","roleDisplay":"VerfasserIn","display":"Geletneky, Karsten","role":"aut"},{"given":"Johannes","family":"Hüsing","role":"aut","roleDisplay":"VerfasserIn","display":"Hüsing, Johannes"},{"given":"Magnus von","family":"Knebel Doeberitz","role":"aut","display":"Knebel Doeberitz, Magnus von","roleDisplay":"VerfasserIn"},{"role":"aut","display":"Hajda, Jacek","roleDisplay":"VerfasserIn","given":"Jacek","family":"Hajda"}],"title":[{"title":"Phase I/IIa study of intratumoral/intracerebral or intravenous/intracerebral administration of Parvovirus H-1 (ParvOryx) in patients with progressive primary or recurrent glioblastoma multiforme","subtitle":"ParvOryx01 protocol","title_sort":"Phase I/IIa study of intratumoral/intracerebral or intravenous/intracerebral administration of Parvovirus H-1 (ParvOryx) in patients with progressive primary or recurrent glioblastoma multiforme"}],"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"id":{"eki":["326643710"],"zdb":["2041352-X"],"issn":["1471-2407"]},"origin":[{"publisher":"BioMed Central ; Springer","dateIssuedKey":"2001","dateIssuedDisp":"2001-","publisherPlace":"London ; Berlin ; Heidelberg"}],"part":{"extent":"9","text":"12(2012) Artikel-Nummer 99, 9 Seiten","volume":"12","year":"2012"},"pubHistory":["1.2001 -"],"recId":"326643710","language":["eng"],"note":["Gesehen am 22.05.20"],"type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"Phase I/IIa study of intratumoral/intracerebral or intravenous/intracerebral administration of Parvovirus H-1 (ParvOryx) in patients with progressive primary or recurrent glioblastoma multiforme ParvOryx01 protocolBMC cancer","title":[{"title":"BMC cancer","title_sort":"BMC cancer"}]}],"physDesc":[{"extent":"9 S."}],"name":{"displayForm":["Karsten Geletneky, Johannes Huesing, Jean Rommelaere, Joerg R. Schlehofer, Barbara Leuchs, Michael Dahm, Ottheinz Krebs, Magnus von Knebel Doeberitz, Bernard Huber and Jacek Hajda"]},"id":{"eki":["1572512350"],"doi":["10.1186/1471-2407-12-99"]},"origin":[{"dateIssuedKey":"2012","dateIssuedDisp":"21 March 2012"}]} | ||
| SRT | |a GELETNEKYKPHASEIIIAS2120 | ||